Aequita Bioworks provides an automated, AI‑driven laboratory platform that performs sterility testing for pharmaceuticals, delivering validated results in 20–24 hours instead of the traditional 14 days. The system combines robotic sample handling, rapid microbial detection, and machine‑learning analytics, offering high‑throughput, compliance‑ready testing for 503A compounding pharmacies and larger manufacturers through a secure cloud‑based dashboard.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical quality control relies on sterility testing that traditionally requires up to 14 days to deliver results, delaying product release and increasing inventory costs. Slow turnaround hampers rapid response to market demand and can extend the time patients wait for critical medications.
Solution
Aequita Bioworks offers an automated, AI‑driven laboratory platform that performs sterility assays and delivers reliable results within approximately 20–24 hours. The system integrates robotic sample handling, rapid microbial detection methods, and machine‑learning analytics to accelerate culture growth and interpret outcomes without manual intervention. By consolidating the entire testing workflow into a single, scalable infrastructure, the platform provides consistent, high‑throughput sterility assessment for 503A compounding pharmacies and larger pharmaceutical manufacturers. Clients can submit samples and receive validated results through a secure online portal, enabling faster release decisions and reduced holding times.
Target Audience
Primary customers are pharmaceutical manufacturers and 503A compounding pharmacies that require rapid, compliant sterility testing for product release.
Features
- Fully robotic sample preparation and inoculation to eliminate manual handling errors
- AI‑enhanced detection algorithms that identify microbial growth earlier than conventional culture methods
- Integrated data management with real‑time result reporting via a cloud‑based dashboard
- Compliance‑ready documentation and audit trails aligned with USP <71> sterility testing standards
- Scalable architecture supporting high‑volume testing for both compounding pharmacies and large manufacturers